Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9345905
APP PUB NO 20140322229A1
SERIAL NO

14361278

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present document describes compounds of Formula I, pharmaceutical compositions comprising the same as well as methods of treating diseases such as a cancer, neurological disease, neurodegenerative disorder, stroke, traumatic brain injury, parasitic infection, inflammation or an autoimmune disease with said compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BETA PHARMA CANADA INC6100 AVENUE ROYALMOUNT MONTREAL QUEBEC H4P 2R2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Lianhai Pierrefonds, CA 22 140
Wang, Zhaoyin Kirkland, CA 73 1827

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00